The design and interpretation of pilot trials in clinical research in critical care

被引:144
作者
Arnold, Donald M. [1 ]
Burns, Karen E. A. [2 ]
Adhikari, Neill K. J. [2 ]
Kho, Michelle E. [3 ]
Meade, Maureen O. [1 ,3 ]
Cook, Deborah J. [1 ,3 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada
[3] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
关键词
pilot trials; pilot studies; randomized trials; clinical research; critical care; RESPIRATORY-DISTRESS-SYNDROME; INJURY TRIAL; ILL PATIENTS; LUNG INJURY; PROPHYLAXIS; VENTILATION; GLUCOSE; PHASE; CELLS;
D O I
10.1097/CCM.0b013e3181920e33
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Pilot trials are important to ensure that large randomized trials are rigorous, feasible, and economically justifiable. The objective of this review is to highlight the importance of randomized pilot trials and to describe key features of their design and interpretation using examples from critical care. Methods: We searched MEDLINE (1997-2007) and contacted experts to identify pilot randomized trials to exemplify and summarize their key methodologic features including objectives, sample size determination, outcomes, analysis, and reporting. Results: Pilot trials can have distinct and broad objectives. Investigators can predefine explicit criteria for determining their success. Surrogate outcome analyses are common in pilot trials, yet are usually underpowered to detect meaningful differences in clinically important end points and thus, should be cautiously interpreted. Pilot trials can facilitate successful conduct of large clinical trials by informing study design and streamlining protocol implementation. Recommendations: We recommend that investigators define suitable objectives, determine sample size estimates, and select outcomes that will address their specific pilot trial objectives. Clinical effects documented in pilot trials should be reported with caution to avoid undue enthusiasm or pessimism about unstable estimates. Further methodologic work is required to identity optimal pilot trial design, indexing, and reporting. (Crit Care Med 2009; 37[Suppl.]:S69-S74)
引用
收藏
页码:S69 / S74
页数:6
相关论文
共 27 条
[1]  
[Anonymous], 2010, OSCILLATION ARDS TRE
[2]   Glycemic control in the intensive care unit: Why we should wait for NICE-SUGAR [J].
Bellomo, R ;
Egi, M .
MAYO CLINIC PROCEEDINGS, 2005, 80 (12) :1546-1548
[3]   Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients [J].
Brower, RG ;
Shanholtz, CB ;
Fessler, HE ;
Shade, DM ;
White, P ;
Wiener, CM ;
Teeter, JG ;
Dodd-o, JM ;
Almog, Y ;
Piantadosi, S .
CRITICAL CARE MEDICINE, 1999, 27 (08) :1492-1498
[4]   Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. [J].
Brower, RG ;
Matthay, MA ;
Morris, A ;
Schoenfeld, D ;
Thompson, BT ;
Wheeler, A ;
Wiedemann, HP ;
Arroliga, AC ;
Fisher, CJ ;
Komara, JJ ;
Perez-Trepichio, P ;
Parsons, PE ;
Wolkin, R ;
Welsh, C ;
Fulkerson, WJ ;
MacIntyre, N ;
Mallatratt, L ;
Sebastian, M ;
McConnell, R ;
Wilcox, C ;
Govert, J ;
Thompson, D ;
Clemmer, T ;
Davis, R ;
Orme, J ;
Weaver, L ;
Grissom, C ;
Eskelson, M ;
Young, M ;
Gooder, V ;
McBride, K ;
Lawton, C ;
d'Hulst, J ;
Peerless, JR ;
Smith, C ;
Brownlee, J ;
Pluss, W ;
Kallet, R ;
Luce, JM ;
Gottlieb, J ;
Elmer, M ;
Girod, A ;
Park, P ;
Daniel, B ;
Gropper, M ;
Abraham, E ;
Piedalue, F ;
Glodowski, J ;
Lockrem, J ;
McIntyre, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1301-1308
[5]   Multicenter clinical research in adult critical care [J].
Cook, D ;
Brower, R ;
Cooper, J ;
Brochard, L ;
Vincent, JL .
CRITICAL CARE MEDICINE, 2002, 30 (07) :1636-1643
[6]   Prophylaxis of Thromboembolism in Critical Care (PROTECT)Trial:: a pilot study [J].
Cook, DJ ;
Rocker, G ;
Meade, M ;
Guyatt, G ;
Geerts, W ;
Anderson, D ;
Skrobik, Y ;
Hebert, P ;
Albert, M ;
Cooper, J ;
Bates, S ;
Caco, C ;
Finfer, S ;
Fowler, R ;
Freitag, A ;
Granton, J ;
Jones, G ;
Langevin, S ;
Mehta, S ;
Pagliarello, G ;
Poirier, G ;
Rabbat, C ;
Schiff, D ;
Griffith, L ;
Crowther, M .
JOURNAL OF CRITICAL CARE, 2005, 20 (04) :364-372
[7]   Systematic reviews: Synthesis of best evidence for clinical decisions [J].
Cook, DJ ;
Mulrow, CD ;
Haynes, RB .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (05) :376-380
[8]   Clinical trial registration: a statement from the International Committee of Medical Journal Editors [J].
De Angelis, C ;
Drazen, JM ;
Frizelle, FA ;
Haug, C ;
Hoey, J ;
Horton, R ;
Kotzin, S ;
Laine, C ;
Marusic, A ;
Overbeke, AJPM ;
Schroeder, TV ;
Sox, HC ;
Van Der Weyden, MB .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (06) :606-607
[9]   Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin -: An assessment of safety and pharmacodynamics:: The DIRECT study [J].
Douketis, James ;
Cook, Deborah ;
Meade, Maureen ;
Guyatt, Gordon ;
Geerts, William ;
Skrobik, Yoanna ;
Albert, Martin ;
Granton, John ;
Hebert, Paul ;
Pagliarello, Guiseppe ;
Marshall, John ;
Fowler, Robert ;
Freitag, Andreas ;
Rabbat, Christian ;
Anderson, David ;
Zytaruk, Nicole ;
Heels-Ansdell, Diane ;
Crowther, Mark .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (16) :1805-1812
[10]  
Eisebitt R, 1999, EUR J SURG, V163, P68